IOVA Simply Wall St. 21 hours ago Assessing Iovance Biotherapeutics (IOVA) Valuation After Recent Share Price Volatility
IOVA Simply Wall St. a day ago Is It Time To Reconsider Iovance Biotherapeutics (IOVA) After Prolonged Share Price Weakness
IOVA Insider Monkey 2 days ago Iovance Biotherapeutics (IOVA) Gives Update on Revenue Guidance, Lung Cancer Cure
IOVA GlobeNewswire 3 days ago Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
